OptimizeRx Corporation increased earnings guidance for the year 2023. For the year, the company now expects revenue to be between $68 million and $70 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.54 USD | -2.54% | -0.52% | -26.17% |
Apr. 29 | OptimizeRx Corporation Provides Earnings Guidance for the First Quarter of 2024 | CI |
Apr. 16 | Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.17% | 197M | |
+28.81% | 441B | |
+26.53% | 263B | |
+7.32% | 140B | |
+8.07% | 92.89B | |
+28.40% | 90.53B | |
+53.69% | 58.64B | |
+17.82% | 46.96B | |
+1.67% | 36.7B | |
+20.56% | 36.11B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- OptimizeRx Corporation Increases Earnings Guidance for the Year 2023